You are here
COVID-19-related application for consent to supply goods that do not conform with Therapeutic Goods Order No. 92 - Standard for labels of non-prescription medicines - section 14/14A
The COVID-19 pandemic has placed unprecedented pressures and challenges on the pharmaceutical industry, including difficulty in implementing the new medicine labels that comply with the new labelling orders (TGO 91/92) for medicines that came into force on 1 September 2020.
In recognition of these challenges, the Therapeutic Goods Administration (TGA) established a temporary process for sponsors of listed, registered complementary, and over-the-counter (OTC) medicines to request consent to supply products that do not comply with TGO 92 due to adverse business impacts of COVID-19. The end date for this consent was 6 March 2021.